Study of Romosozumab in People With Breast Cancer and Osteoporosis

Full Title

A Phase II Study Evaluating the Efficacy and Safety of Romosozumab as a Bone-Modifying Agent in Patients with Metastatic Breast Cancer to Bones and Osteoporosis with High Fracture Risk (REMOLD-Breast)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Monica Fornier’s office at 646-888-5240.

Protocol
26-191
Phase
Phase II (phase 2)
Investigator
Monica N. Fornier
Co-Investigators
Jasmeet C. Singh
Diseases
Breast Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07776613
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description